239 related articles for article (PubMed ID: 29760186)
1. Hypertrophic cardiomyopathy mutations increase myofilament Ca
Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
[TBL] [Abstract][Full Text] [Related]
2. Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.
Helms AS; Alvarado FJ; Yob J; Tang VT; Pagani F; Russell MW; Valdivia HH; Day SM
Circulation; 2016 Nov; 134(22):1738-1748. PubMed ID: 27688314
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
5. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
6. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.
McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP
Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598
[TBL] [Abstract][Full Text] [Related]
7. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.
Mickelson AV; Chandra M
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1180-H1189. PubMed ID: 28842439
[TBL] [Abstract][Full Text] [Related]
10. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Robinson P; Griffiths PJ; Watkins H; Redwood CS
Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
[TBL] [Abstract][Full Text] [Related]
11. Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.
Guinto PJ; Haim TE; Dowell-Martino CC; Sibinga N; Tardiff JC
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H614-26. PubMed ID: 19502551
[TBL] [Abstract][Full Text] [Related]
12. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.
Crocini C; Ferrantini C; Scardigli M; Coppini R; Mazzoni L; Lazzeri E; Pioner JM; Scellini B; Guo A; Song LS; Yan P; Loew LM; Tardiff J; Tesi C; Vanzi F; Cerbai E; Pavone FS; Sacconi L; Poggesi C
J Mol Cell Cardiol; 2016 Feb; 91():42-51. PubMed ID: 26714042
[TBL] [Abstract][Full Text] [Related]
13. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
Redwood CS; Moolman-Smook JC; Watkins H
Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
[TBL] [Abstract][Full Text] [Related]
14. CaMKII-mediated phosphorylation of RyR2 plays a crucial role in aberrant Ca
Okuda S; Sufu-Shimizu Y; Kato T; Fukuda M; Nishimura S; Oda T; Kobayashi S; Yamamoto T; Morimoto S; Yano M
Biochem Biophys Res Commun; 2018 Feb; 496(4):1250-1256. PubMed ID: 29402414
[TBL] [Abstract][Full Text] [Related]
15. Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
Messer AE; Bayliss CR; El-Mezgueldi M; Redwood CS; Ward DG; Leung MC; Papadaki M; Dos Remedios C; Marston SB
Arch Biochem Biophys; 2016 Jul; 601():113-20. PubMed ID: 27036851
[TBL] [Abstract][Full Text] [Related]
16. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
17. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
[TBL] [Abstract][Full Text] [Related]
18. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
Chandra V; Gollapudi SK; Chandra M
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
[TBL] [Abstract][Full Text] [Related]
19. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
20. Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.
Zile MA; Trayanova NA
Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):418-428. PubMed ID: 28648627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
